Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
PR Quesada, LL Esteban, JR García… - International journal of …, 2015 - Springer
Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
PR Quesada, LL Esteban, JR García… - … Journal of Clinical …, 2015 - search.proquest.com
Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
PR Quesada, LL Esteban, JR García… - … journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
P Rodríguez Quesada, L López Esteban… - 2015 - cabidigitallibrary.org
Background: Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
INCIDENCE AND RISK FACTORS FOR TENOFOVIR-ASSOCIATED RENAL TOXICITY IN HIV-INFECTED PATIENTS.
P Rodríguez-Quesada, L López-Esteban… - eahp.eu
INCIDENCE AND RISK FACTORS FOR TENOFOVIR-ASSOCIATED RENAL TOXICITY IN
HIV-INFECTED PATIENTS. Page 1 INCIDENCE AND RISK FACTORS FOR TENOFOVIR-ASSOCIATED …
HIV-INFECTED PATIENTS. Page 1 INCIDENCE AND RISK FACTORS FOR TENOFOVIR-ASSOCIATED …
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
PR Quesada, LL Esteban, JR García… - International Journal of …, 2015 - infona.pl
Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
PR Quesada, LL Esteban, JR García… - … Journal of Clinical …, 2015 - europepmc.org
Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …